Stereotactic radiotherapy for pulmonary oligometastases: A systematic review

Journal of Thoracic Oncology

Volumn 5, Issue 7, 2010, Pages 1091-1099

  Siva, Shankar ^a   MacManus, Michael ^a   Ball, David ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Lung; Metastases; Radiosurgery; Radiotherapy; Stereotactic

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HUMAN; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; OVERALL SURVIVAL; PERICARDIAL EFFUSION; PNEUMOTHORAX; PRIORITY JOURNAL; PULMONARY OLIGOMETASTASIS; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PNEUMONIA; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUMOR VOLUME; LUNG NEOPLASMS; METASTASIS; PATHOLOGY; RADIOSURGERY;

HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; RADIOSURGERY;

EID: 77954425611     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181de7143     Document Type: Review

References (46)

1. Saxman SB, Finch D, Gonin R, et al. Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience. J Clin Oncol 1998;16:702-706. (Pubitemid 28135618)
2. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995;13: 8-10.
3. Norton L, Simon R. The Norton-Simon hypothesis revisited. Cancer Treat Rep 1986;70:163-169. (Pubitemid 16140378)
4. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998;280:1485-1489. (Pubitemid 28507400)
5. Simmonds PC, Primrose JN, Colquitt JL, et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006;94:982-999.
6. Steele G Jr, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 1989;210:127-138.
7. Tanvetyanon T, Robinson LA, Schell MJ, et al. Outcomes of adrenal-ectomy for isolated synchronous versus metachronous adrenal metasta-ses in non-small-cell lung cancer: a systematic review and pooled analysis. J Clin Oncol 2008;26:1142-1147.
8. Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997;113:37-49. (Pubitemid 27034340)
9. Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951;102:316-319.
10. Lax I, Blomgren H, Näslund I, et al. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994;33:677-683. (Pubitemid 24345376)
11. Le QT, Loo BW, Ho A, et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol 2006;1:802-809. (Pubitemid 47181385)
12. McGarry RC, Papiez L, Williams M, et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005;63:1010-1015. (Pubitemid 41505277)
13. Schefter TE, Kavanagh BD, Raben D, et al. A phase I/II trial of stereotactic body radiation therapy (SBRT) for lung metastases: initial report of dose escalation and early toxicity. Int J Radiat Oncol Biol Phys 2006;66:120-127. (Pubitemid 44633564)
14. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-694.
15. Guerrero M, Li XA. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol 2004;49:4825-4835. (Pubitemid 39433509)
16. Nakagawa K, Aoki Y, Tago M, et al. Megavoltage CT-assisted stereo-tactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms. Int J Radiat Oncol Biol Phys 2000;48:449-457.
17. Hara R, Itami J, Kondo T, et al. Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol 2002;63:159-163. (Pubitemid 34628404)
18. Wulf J, Baier K, Mueller G, et al. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 2005;77:83-87. (Pubitemid 41503394)
19. Fritz P, Kraus HJ, Mühlnickel W, et al. Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol 2006;1:30.
20. Hof H, Hoess A, Oetzel D, et al. Stereotactic single-dose radiotherapy of lung metastases. Strahlenther Onkol 2007;183:673-678. (Pubitemid 350175409)
21. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006;24:4833-4839. (Pubitemid 46630909)
22. Blomgren H, Lax I, Nöslund I, et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator: clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861-870.
23. Lax I, Blomgren H, Larson D, et al. Extracranial stereotactic radiosur-gery of localized targets. J Radiosurg 1998;1:135-148.
24. Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 1998;82:1062-1070. (Pubitemid 28136518)
25. Nagata Y, Negoro Y, Aoki T, et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2001;51:352-353. (Pubitemid 34219025)
26. Onimaru R, Shirato H, Shimizu S, et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003;56:126-135. (Pubitemid 36403684)
27. Guckenberger M, Heilman K, Wulf J, et al. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study. Radiother Oncol 2007;85:435-442. (Pubitemid 350213147)
28. Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004;60:186-196. (Pubitemid 39165484)
29. Song DY, Benedict SH, Cardinale RM, et al. Stereotactic body radiation therapy of lung tumors: preliminary experience using normal tissue complication probability-based dose limits. Am J Clin Oncol 2005;28: 591-596.
30. Min Yoon S, Kyung Choi E, Lee SW, et al. Clinical results of stereo-tactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors. Acta Oncol 2006;45:1108-1114.
31. Aoki M, Abe Y, Kondo H, et al. Clinical outcome of stereotactic body radiotherapy of 54 Gy in nine fractions for patients with localized lung tumor using a custom-made immobilization system. Radiat Med 2007; 25:289-294. (Pubitemid 351928044)
32. Milano MT, Katz AW, Muhs AG, et al. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 2008;112:650-658.
33. Milano MT, Katz AW, Schell MC, et al. Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2008;72:1516-1522.
34. Okunieff P, Petersen AL, Philip A, et al. Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol 2006;45:808-817. (Pubitemid 44423126)
35. Norihisa Y, Nagata Y, Takayama K, et al. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 2008;72:398-403.
36. Brown W, Wu X, Fowler J, et al. Lung metastases treated by CyberKnife image-guided robotic stereotactic radiosurgery at 41 months. South Med J 2008;101:376-382. (Pubitemid 351507510)
37. Salazar OM, Sandhu TS, Lattin PB, et al. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers. Int J Radiat Oncol Biol Phys 2008;72:707-715.
38. Rusthoven KE, Kavanagh BD, Burri SH, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009;27:1579-1584.
39. Guckenberger M, Meyer J, Wilbert J, et al. Cone-beam CT based image-guidance for extracranial stereotactic radiotherapy of intrapulmo-nary tumors. Acta Oncol 2006;45:897-906. (Pubitemid 44423138)
40. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623-1631. (Pubitemid 39318910)
41. Xiao Y, Papiez L, Paulus R, et al. Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2009;73:1235-1242.
42. McGarry RC, Papiez L, Williams M, et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005;63:1010-1015. (Pubitemid 41505277)
43. Timmerman RD, Story M. Stereotactic body radiation therapy: a treatment in need of basic biological research. Cancer J 2006;12:19-20.
44. Takeda A, Kunieda E, Takeda T, et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2008;70:1057-1065. (Pubitemid 351296119)
45. Henderson MA, Hoopes DJ, Fletcher JW, et al. A pilot trial of serial 18f-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010;76:789-795.
46. Guckenberger M, Meyer J, Vordermark D, et al. Magnitude and clinical relevance of translational and rotational patient setup errors: a cone-beam CT study. Int J Radiat Oncol Biol Phys 2006;65:934-942. (Pubitemid 43795840)